1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Psoriatic Arthritis-Pipeline Insights, 2017

Psoriatic Arthritis-Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight


DelveInsight’s, “ Psoriatic Arthritis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Psoriatic Arthritis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Psoriatic Arthritis. DelveInsight’s Report also assesses the Psoriatic Arthritis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Psoriatic Arthritis
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Psoriatic Arthritis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Psoriatic Arthritis and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Psoriatic Arthritis-Pipeline Insights, 2017
Illustrative

- Psoriatic Arthritis Overview
- Psoriatic Arthritis Pipeline Therapeutics
- Psoriatic Arthritis Therapeutics under Development by Companies
- Psoriatic Arthritis Filed and Phase III Products
- Comparative Analysis
- Psoriatic Arthritis Phase II Products
- Comparative Analysis
- Psoriatic Arthritis Phase I and IND Filed Products
- Comparative Analysis
- Psoriatic Arthritis Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Psoriatic Arthritis - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Psoriatic Arthritis - Discontinued Products
- Psoriatic Arthritis - Dormant Products
- Companies Involved in Therapeutics Development for Psoriatic Arthritis
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Psoriatic Arthritis, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Psoriatic Arthritis Assessment by Monotherapy Products
- Psoriatic Arthritis Assessment by Combination Products
- Psoriatic Arthritis Assessment by Route of Administration
- Psoriatic Arthritis Assessment by Stage and Route of Administration
- Psoriatic Arthritis Assessment by Molecule Type
- Psoriatic Arthritis Assessment by Stage and Molecule Type
- Psoriatic Arthritis Therapeutics - Discontinued Products
- Psoriatic Arthritis Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Psoriatic Arthritis, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Psoriatic Arthritis Assessment by Monotherapy Products
- Psoriatic Arthritis Assessment by Combination Products
- Psoriatic Arthritis Assessment by Route of Administration
- Psoriatic Arthritis Assessment by Stage and Route of Administration
- Psoriatic Arthritis Assessment by Molecule Type
- Psoriatic Arthritis Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025) Factors such as increased focus on human microbiome ...

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Ankylosing spondylitis (AS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.